Heart failure with preserved ejection fraction: diagnosis and treatment
Milashchenko A.I., Ibragimov M.S., Andreev A.N., Kozlov P.A.
Abstract. The articlesummarizes and analyzes the data in the modern literature about know diagnosis and treatment of heart failure with preserved ejection fraction. Approximately 30-50% of patients with heart failure have normal or near normal left ventricular systolic function. The clinical profile, readmissions and mortalityare comparable to that of heart failure with reduced ejection fraction.Diagnosis of heart failure with nomalejection fractionis frequently challenging and relies upon careful clinicalevaluation, tissue Doppler imaging, echo-Doppler cardiography,the level of natriuretic peptides and invasive haemodynamic assessment.Currently, no clinically proven treatments are shown to decrease morbidity and mortality in this population; however, there are novel treatment strategies that are currently under investigation or hold promise for the future.
Keywords: heart failure with preserved ejection fraction, diastolic dysfunction, chronic heart failure
REFERENCES
1. Bhatia R. S., Tu J. V., Lee D. S. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 2006, 355: 260–269.
2. Hogg K., Swedberg K., McMurray J.: Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am CollCardiol 2004, 43:317-327.
3. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355(3): 251-259
4. Owan T.E., Redfield M.M. Epidemiology of diastolic heart failure. Prog.Cardiovasc.Dis. 2005, 47: 320-332.
5. Dougherty AH, Naccarelli GV, Grey EL, et al. 1984. Congestive heart failure with normal systolic function. Am J Cardiol 54:778–782.
6. Echeverria HH, Bilsker MS, Myerburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med, 1983; 75:750-5.
7. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., Krumholz H.M. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am CollCardiol 2003, 41: 1510-1518
8. Monnet X. Insuffisancecardiaqueaiguëdiastolique. Réanimation 2008, 17 (2): 146–152
9. Vasan, R. S., Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101: 2118–2121
10. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiog 2009, 10: 165–193
11. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., Quinones M.A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am CollCardiol 1997, 30: 1527–1533
12. Maurer M.S., King D.L., El-KhouryRumbarger L., Packer M., Burkhoff D. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J CardFail 2005, 11: 177–187.
13. Munagala V.K., Burnett J.С Jr., Redfield M.M. The natriuretic peptides in cardiovascular medicine. Curr.Probl.Cardiol. 2004; 29: 707-769
14. Walter J. Paulus, CarstenTschope, J.E. Sanderson еt al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 2007, 28: 2539-2550
15. Arbab-Zadeh A., Dijk E., Prasad A., Fu Q., Torres P., Zhang R., Thoma J.D., Palmer D.M., Levine BD Effect of Aging and Physical Activity on Left Ventricular Compliance. Circulation 2004, 110(13): 1799-1805
16. Heart Failure Society of America, Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline, J Card Fail, 2006; 12:10–38.
17. Cleland J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Hot Line .I Session on XVth World Congress of Cardiology, Barcelona, 03 .September .2006
18. Kuimov A.D., Beljaeva O.N., Volkova I.I. i dr. Vlijanie IAPF lizinoprilananarushenijadiastolicheskojfunkciilevogozheludochka i najendotelial'nyjotvet u bol'nyharterial'nojgipertenziej s hronicheskojserdechnojnedostatochnost'ju i bez nee. [Effect of ACE inhibitor lisinopril violations of left ventricular diastolic function and endothelial response in hypertensive patients with chronic heart failure and without]Rossijskijkardiologicheskijzhurnal. — 2004.-N 3:58-63(in Russian)
19. Yusuf S., Pfeffer M.A., Swedberg K. et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362(9386): 777–781
20. MareevV.Ju., Ovchinnikov A.G., Ageev F.T., BelenkovJu.N. Vlijanieingibitorov APF i antagonistovreceptorov k angiotenzinu-II nadiastolicheskujufunkcijulevogozheludochka u pacientov s otnositel'nosohrannojsistolicheskojfunkciejlevogozheludochka: rezul'tatyissledovanija «Perindopril, IRbesartan i AmlodipiN u bol'‘nyh s HSN i sohranennojsistolicheskojfunkciejlevogozheludochka (PIRAN’'ja). [Effect of ACE inhibitors and angiotensin receptor antagonists-II in left ventricular diastolic function in patients with relatively preserved left ventricular systolic function: the results of the study «Perindopril, irbesartan and amlodipine in patients with heart failure and preserved left ventricular systolic function (Piranha)]ZhurnalSerdechnaja Nedostatochnost',2005; №6 (1):4-14(in Russian)
21. MassieB.M., CarsonP.E., McMurrayJ.J., etal. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. N Engl J Med 2008; 359: 2456—2467
22. Solomon S.D., Janardhanan R., Verma A., et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007, 369(9579): 2079-2087
23. Flather M.D., Shibata M.C., Coats A.J. et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J. 2005, 26(3): 215–225
24. Bergstrom A., Andersson B., Edner M., Nylander E., Persson H., Dahlstrom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). European Journal of Heart Failure 2004; 6(4):453-461
25. Hernandez A.F., Hammill B.G., O’Connor C.M., Schulman K.A., Curtis L.H., Fonarow G.C. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (organized program to initiate lifesaving treatment in hospitalized patients with heart failure) registry. JAmCollCardiol 2009, 53(2):184–192
26. Bohua M.R., DaushviliJe.R., Nadiradze N.B., Maglakelidze T.A. Izmeneniesistolicheskoj i diastolicheskojfunkcijlevogozheludochkaprilecheniiarterial'nojgipertenziinormodipinom.[Changing the systolic and diastolic functions levogozheludochka in the treatment of hypertension normodipin]GedeonRihter v SNG, 2002; №1: 19—20.(in Russian)
27. MareevV.Ju. Izmeneniestrategiilechenijahronicheskojserdechnojnedostatochnosti.Vremjaβadrenoblokatorov.[Change Strategy treatment of chronic heart failure.Time β blockers.]Kardiologija, 1998; № 12: 4-11(in Russian)
28. DevereuxR.B., AlonsoD.R.. et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 1986, 57: 450 — 458.
29. Feigenbaum H. Echocardiography, 4-th. Philadelphia: Lea and Feibiger, 1986.
30. Gilbert J.C., Glantz S.A. Determinants of left ventricular filling and of the diastolic press volume relation. Cipc. Res. 1989, 64: 827 -852
31. Yip GW, Wang M, Wang T. et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart. 2008, 94(5): 573-80
32. Kurrelmeyer K.M., Ashton Y., Xu J., Nagueh S.F., Torre-Amione G., Deswal A. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2014, 20(8): 560-568.
33. Ahmed A., Rich M.W., Fleg J.L. et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 2006, 114(5): 397–403
Authors
MilashchenkoAngeliya I.
Ural State Medical University
The second-year resident of Hospital TherapyDepartment
milashchenko-ai@yandex.ru
IbragimovMubariz S.
Municipal budgetary central clinical city hospital number 24, Department of Intensive Care, Yekaterinburg, Russian Federation
PhD, Assistant Professor of Hospital TherapyDepartment
Russian Federation, Yekaterinburg, Rizhskij 16
ibragimovmd@yandex.ru
Andreev Arkadij N.
Ural State Medical University
MD, Professor, Head of Hospital Therapy Department;
Russian Federation, Yekaterinburg, Repina 3
KozlovPavel A.
Ural State Medical University
Postgraduate of Hospital TherapyDepartment,
axe_p@mail.ru
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)